The molecular perspective suggests that elevated IGF-1, increased cytokine and estrogen levels, adipokine imbalances, and hyperinsulinemia contribute to a high risk of malignancy besides leading to poorer patient outcomes (Howe et al., 2013). Here, IGF1 is linked to hyperinsulinism.